EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-1,193 Cr | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr |
What is the latest Cash Flow from Investing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-1,193 Cr |
| Mar2025 | ₹-94 Cr |
| Mar2024 | ₹-713 Cr |
| Mar2023 | ₹-468 Cr |
| Mar2022 | ₹-789 Cr |
How is Cash Flow from Investing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,193 Cr | Negative | |
| Mar2025 | ₹-94 Cr | Negative | |
| Mar2024 | ₹-713 Cr | Negative | |
| Mar2023 | ₹-468 Cr | Negative | |
| Mar2022 | ₹-789 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,234.6 Cr | -2.6% | 1.7% | 40.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.6% |
1.7% |
40.3% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses